George Tziras
Vermogen: 165 029 $ op 31-05-2026
Vermogen: 165 029 $ op 31-05-2026
George Tziras currently works at Small Pharma, Inc., as Chief Executive Officer & Director from 2022, Cybin UK Ltd., as Non-Executive Director from 2015, and Cybin, Inc., as Chief Business Officer from 2025.
Mr. Tziras also formerly worked at Unilock Capital Corp., as Chief Business Officer & Director.
Mr. Tziras received his undergraduate degree from the University of Oxford and graduate degree from The Paul H.
Nitze School of Advanced International Studies.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CYBIN, INC. 0,07% | 20-02-2026 | 36.270 ( 0,07% ) | 165 029 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SMALL PHARMA INC. | Algemeen Directeur | 20-07-2022 |
| CYBIN INC. | Corporate Officer/Principal | 23-10-2023 |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Directeur/Bestuurslid | 01-01-2015 |
| Bedrijven | Functie | Einde |
|---|---|---|
| SMALL PHARMA INC. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Paul H. Nitze School of Advanced International Studies
The Paul H. Nitze School of Advanced International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Health Technology |
Unilock Capital Corp.
Unilock Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Small Pharma, Inc.
Small Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuro pharmaceutical company that develops therapeutic treatments for mental health disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau